

EDUCATION AND TRAINING
MD, Rush Medical College, Chicago, IL
Residency, University of Washington, Department of Internal Medicine and Department of
Medicine
Fellowship, University of Washington, Division of Metabolism, Endocrinology and Nutrition
|
|
Michael W. Schwartz, M.D.
Professor of Medicine
Division of Metabolism, Endocrinology and Nutrition
Section Head, Clinical Nutrition
OFFICE ADDRESS
Harborview Medical Center
325 Ninth Avenue
UW Mailbox 359675
Seattle, WA 98104-2499
CURRENT RESEARCH INTERESTS
Physiological mechanisms underlying body weight regulation and the
pathogenesis of obesity and diabetes. Major questions
under investigation are: (1) By what mechanism do circulating signals
involved in the regulation of body adiposity, including insulin and leptin,
act in the brain? (2) Which specific hypothalamic pathways are
sensitive to the actions of insulin and leptin, and what is the cellular
basis for these actions? (3) What are the behavioral and metabolic
consequences of the actions of insulin and leptin on their hypothalamic
targets? (4) What mechanism is responsible for hypothalamic
resistance to these hormones in obese individuals? (5) Do
neurocircuits involved in food intake also regulate insulin action in
peripheral tissues?
REPRESENTATIVE PUBLICATIONS
Schwartz MW, Woods SC, Seeley RJ, Porte D Jr, and Baskin DG: Central
nervous system control of food intake. Nature 404:661-671, 2000.
Schwartz MW: Staying slim with insulin in mind. Science 2089:266-267, 2000.
Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG, and Schwartz
MW: Key enzyme in leptin-induced anorexia. Nature 413:794-795, 2001.
Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG Jr,
Seeley RJ, Schwartz MW: Insulin activation of
phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: A
key mediator of insulin-induced anorexia. Diabetes 52:227-231,
2003.
Schwartz MW and Porte D Jr: Diabetes, obesity, and the
brain. Science 307:375-379, 2005.
Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes
CJ, Baskin DG, and Schwartz MW: Leptin action in the forebrain
regulates the hindbrain response to satiety signals. J Clin
Invest 115:703-710, 2005.
Porte D Jr, Baskin DG, and Schwartz MW: Insulin signaling in the
central nervous system: A critical role in metabolic homeostasis
and disease from C. elegans to humans. Diabetes 54:1264-1276,
2005.
Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz
MW: Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase
signaling in mediobasal hypothalamic neurons. Cell Metab
2:411-20, 2005.
Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS: PI3K integrates the action of insulin and leptin on hypothalamic
neurons. J Clin Invest 115:951-8, 2005.
Williams DL, Baskin DG, Schwartz MW: Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor
stimulation. Diabetes 55:3387-93, 2006.
Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body
weight. Nature 443:289-95, 2006.
Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers MG Jr, Rhodes CJ,
Schwartz MW: Insulin action in the brain contributes to glucose lowering during insulin
treatment of diabetes. Cell Metab 3:67-73, 2006.
Williams DL, Baskin DG, Schwartz MW: Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor
stimulation. Diabetes 55:3387-93, 2006.
Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD, Cui L, Beyer RP, Easley CN, Smith
AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, La Spada AR: Thermoregulatory and metabolic defects in Huntington's disease transgenic mice
implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell
Metab 4:349-362, 2006.
Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body
weight. Nature 443:289-295, 2006.
Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines
EW, Schwartz MW: Toll-like receptor-4 mediates vascular inflammation and insulin resistance in
diet-induced obesity. Circ Res 100:1589-1596, 2007.
|